These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 29858985)

  • 1. Predisposing factors to heart failure in diabetic nephropathy: a look at the sympathetic nervous system hyperactivity.
    Komici K; Femminella GD; de Lucia C; Cannavo A; Bencivenga L; Corbi G; Leosco D; Ferrara N; Rengo G
    Aging Clin Exp Res; 2019 Mar; 31(3):321-330. PubMed ID: 29858985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis, Clinical Features and Treatment of Diabetic Cardiomyopathy.
    Alonso N; Moliner P; Mauricio D
    Adv Exp Med Biol; 2018; 1067():197-217. PubMed ID: 28980272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sympathetic nervous system, diabetes, and hypertension.
    Perin PC; Maule S; Quadri R
    Clin Exp Hypertens; 2001; 23(1-2):45-55. PubMed ID: 11270588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Oxidative Stress in Metabolic and Subcellular Abnormalities in Diabetic Cardiomyopathy.
    Dhalla NS; Shah AK; Tappia PS
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity.
    Jia G; Hill MA; Sowers JR
    Circ Res; 2018 Feb; 122(4):624-638. PubMed ID: 29449364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and clinical characteristics of diabetic cardiomyopathy in patients with acute heart failure.
    Matsushita K; Harada K; Kohno T; Nakano H; Kitano D; Matsuda J; Takei M; Yoshino H; Yamamoto T; Nagao K; Takayama M
    Nutr Metab Cardiovasc Dis; 2024 May; 34(5):1325-1333. PubMed ID: 38218713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of AMP-activated protein kinase on cardio-metabolic abnormalities in the development of diabetic cardiomyopathy: A molecular landscape.
    Haye A; Ansari MA; Rahman SO; Shamsi Y; Ahmed D; Sharma M
    Eur J Pharmacol; 2020 Dec; 888():173376. PubMed ID: 32810493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic cardiomyopathy.
    Acar E; Ural D; Bildirici U; Sahin T; Yılmaz I
    Anadolu Kardiyol Derg; 2011 Dec; 11(8):732-7. PubMed ID: 22137942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autophagy in diabetic nephropathy: a review.
    Koch EAT; Nakhoul R; Nakhoul F; Nakhoul N
    Int Urol Nephrol; 2020 Sep; 52(9):1705-1712. PubMed ID: 32661628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Less known pathophysiological mechanisms of anemia in patients with diabetic nephropathy.
    Pappa M; Dounousi E; Duni A; Katopodis K
    Int Urol Nephrol; 2015 Aug; 47(8):1365-72. PubMed ID: 26017902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Cardiac Fibrosis in Diabetic Cardiomyopathy: From Pathophysiology to Clinical Diagnostic Tools.
    Pan KL; Hsu YC; Chang ST; Chung CM; Lin CL
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiovascular protection of diabetic patient with chronic renal disease and particular case of end-stage renal disease in elderly patients].
    Zaoui P; Hannedouche T; Combe C
    Nephrol Ther; 2017 Jun; 13(6S):6S16-6S24. PubMed ID: 29463395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding diabetes-induced cardiomyopathy from the perspective of renin angiotensin aldosterone system.
    Sukumaran V; Gurusamy N; Yalcin HC; Venkatesh S
    Pflugers Arch; 2022 Jan; 474(1):63-81. PubMed ID: 34967935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diabetic cardiomyopathy: concept, heart function, and pathogenesis].
    Codinach Huix P; Freixa Pamias R
    An Med Interna; 2002 Jun; 19(6):313-20. PubMed ID: 12152393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased prevalence of proliferative retinopathy and cardiovascular autonomic dysfunction in IDDM patients with proteinuria.
    Zander E; Seidlein I; Herfurth S; Heinke P; Chlup R; Badendick K; Strese J; Zander G; Schulz B
    Exp Clin Endocrinol; 1992; 99(2):102-7. PubMed ID: 1639116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [AUTOPHAGY AND DIABETIC NEPHROPATHY].
    Farber E; Hanut A; Tadmor H; Ruth A; Nakhoul F; Nakhoul N
    Harefuah; 2021 Nov; 160(11):740-745. PubMed ID: 34817141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The biochemical pharmacology of renin inhibitors: implications for translational medicine in hypertension, diabetic nephropathy and heart failure: expectations and reality.
    Abassi Z; Winaver J; Feuerstein GZ
    Biochem Pharmacol; 2009 Oct; 78(8):933-40. PubMed ID: 19477166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of Animal Models in Diabetic Cardiomyopathy.
    Lee WS; Kim J
    Diabetes Metab J; 2021 Mar; 45(2):129-145. PubMed ID: 33813812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy.
    Jia G; DeMarco VG; Sowers JR
    Nat Rev Endocrinol; 2016 Mar; 12(3):144-53. PubMed ID: 26678809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approaches to prevention of cardiovascular complications and events in diabetes mellitus.
    Coccheri S
    Drugs; 2007; 67(7):997-1026. PubMed ID: 17488145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.